I’ll be attending BIO’s World Congress on Industrial Biotechnology next week (July 19-22, 2015), and I’ll be presenting two talks at breakout sessions. One will discuss the emerging roadmap for gaining regulatory approvals for uses of genetically modified algae in industrial biotechnology; covering topics applicable to uses of any modified microorganism for fuel or chemical production. The other talk will analyze whether existing biotechnology regulatory frameworks are sufficient to cover industrial products developed using synthetic biology. I’ll post copies of my presentations after the conference, and time permitting I’ll try to post some updates on the conference here on the blog. Please contact me with any questions or for more information about my talks.
D. Glass Associates, Inc. is a consulting company specializing in government and regulatory affairs support for renewable fuels and industrial biotechnology. David Glass, Ph.D. is a veteran of over thirty years in the biotechnology industry, with expertise in industrial biotechnology regulatory affairs, U.S. and international renewable fuels regulation, patents, technology licensing, and market and technology assessments. More information on D. Glass Associates’ regulatory affairs consulting capabilities, and copies of some of Dr. Glass’s prior presentations on biofuels and biotechnology regulation, are available at www.slideshare.net/djglass99and at www.dglassassociates.com. The views expressed in this blog are those of Dr. Glass and D. Glass Associates and do not represent the views of any other organization with which Dr. Glass is affiliated. Please visit our other blog, Biofuel Policy Watch.